Pravastatin Drug Profile

What is Pravastatin?

Pravastatin is a prescription medication belonging to a class of drugs called statins, also known as HMG-CoA reductase inhibitors. It is primarily used to lower cholesterol levels in the blood and reduce the risk of cardiovascular events such as heart attacks and strokes. Pravastatin helps manage high cholesterol when diet and lifestyle changes alone are insufficient.

Uses

Pravastatin is approved for several cardiovascular-related conditions:

• High cholesterol (hypercholesterolemia): Reduces LDL (“bad”) cholesterol and total cholesterol levels while modestly increasing HDL (“good”) cholesterol
• Primary prevention of cardiovascular disease: Lowers the risk of heart attacks and strokes in people with elevated cholesterol but no history of heart disease
• Secondary prevention after cardiovascular events: Reduces the risk of repeat heart attacks, strokes, and other cardiovascular complications in patients with established heart disease
• Mixed dyslipidemia: Helps normalize various types of abnormal blood fat levels, including elevated triglycerides
• Familial hypercholesterolemia: Treats inherited conditions causing severely elevated cholesterol levels

How it works

Pravastatin works by blocking an enzyme called HMG-CoA reductase, which plays a crucial role in cholesterol production in the liver. By inhibiting this enzyme, the medication reduces the liver’s ability to manufacture cholesterol, forcing the body to use existing cholesterol stores and remove cholesterol from the bloodstream. This mechanism effectively lowers total cholesterol and LDL cholesterol levels while providing cardiovascular protection.

Side effects

Common side effects include:

Submit Your Paper

• Muscle aches and pain
• Headache
• Nausea and stomach upset
• Diarrhea or constipation
• Dizziness
• Fatigue
• Cold-like symptoms
• Skin rash

Serious side effects to watch for:

• Severe muscle pain, weakness, or tenderness (potential rhabdomyolysis)
• Dark-colored urine or decreased urination
• Liver problems (yellowing of skin or eyes, severe abdominal pain)
• Memory problems or confusion
• New onset diabetes or worsening blood sugar control

Warnings and precautions

• Liver function monitoring: Regular liver enzyme tests are recommended, especially during the first year of treatment, as statins can rarely cause liver damage
• Muscle-related risks: Patients should report any unexplained muscle pain, tenderness, or weakness, particularly if accompanied by fever or fatigue
• Pregnancy and breastfeeding: Pravastatin should not be used during pregnancy or while breastfeeding, as cholesterol is essential for fetal development
• Kidney impairment: Dosage adjustments may be necessary for patients with severe kidney disease
• Age considerations: Elderly patients may be more susceptible to muscle-related side effects and may require lower starting doses

Interactions

Pravastatin can interact with several medications and substances:

• Fibrates (gemfibrozil, fenofibrate): Increase the risk of muscle damage when combined with statins
• Cyclosporine: Significantly increases pravastatin levels, requiring dose adjustments
• Warfarin: May enhance anticoagulant effects, requiring closer monitoring of blood clotting times
• Niacin (high doses): Can increase the risk of muscle-related side effects
• Erythromycin and clarithromycin: These antibiotics may increase statin levels in the blood
• Grapefruit juice: While less significant with pravastatin than other statins, large amounts may still affect drug levels
• Antacids: May reduce pravastatin absorption when taken simultaneously
• Colestipol and cholestyramine: These bile acid sequestrants can reduce pravastatin absorption if taken together

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages for pravastatin range from 10 mg to 80 mg taken once daily, usually in the evening. Most patients start with 20-40 mg daily, with dosage adjustments made based on cholesterol response and tolerance. The maximum recommended dose is 80 mg daily. Patients with kidney impairment may require lower starting doses. Dosage should always be determined and monitored by a healthcare provider, who will consider individual patient factors, cholesterol targets, and response to treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).